about
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesBiomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and othersAllogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factorsStrategies and challenges in eliciting immunity to melanoma.Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases.Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression.High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.Roles of Tregs in development of hepatocellular carcinoma: a meta-analysisIn situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice.The prognostic value of liver tumor T cell infiltratesRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapyThe prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.The prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancerCD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breastIncreased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.Lymphocytic host response to oral squamous cell carcinoma: an adaptive T-cell response at the tumor interface.The changes of angiogenesis and immune cell infiltration in the intra- and peri-tumoral melanoma microenvironment.Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantationDoes the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic dietImmune profiling in human breast cancer using high-sensitivity detection and analysis techniquesResveratrol analogue HS-1793 induces the modulation of tumor-derived T cells.Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.The tumour microenvironment and implications for cancer immunotherapy.Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancerIncreased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.Autologous immune enhancement therapy: A case report of a stage IV colonic cancer.Rebuilding immunity in cancer patients.Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.High metal ion levels after use of the ASR™ device correlate with development of pseudotumors and T cell activation.Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune response.Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?T cells in gastric cancer: friends or foes
P2860
Q26745338-662E940A-29B5-4C08-8CA3-3F029F37BB53Q28072468-5F707656-0116-456A-865D-53A8FB05B0F9Q28652288-36501B3F-3341-46AB-A6F6-5D6EC56F8967Q30435893-7D73A12F-F526-458F-B3D6-5245CD28CF01Q33537482-4767A830-3634-43D8-BE2C-CBA8A756B761Q33638975-FEDAC53A-B133-4B89-B39A-4816C64733D8Q33694988-47D173AA-15F5-4F0B-B4DF-F14C5961BE12Q33739931-50C4980E-F1B0-456D-9CC5-4533927E079CQ33801440-2F2FF00F-9D69-4FD7-8033-99E3ED97CFC4Q33837085-379A059B-C33D-4F47-9255-F2EECDC1BB9AQ34052611-52D9278C-95D1-4C19-B1F2-8A8DC94CF0DEQ34084756-CE3A1DDF-70AD-4DBD-84CA-87C62BD9EECAQ34086276-35A14994-5FFA-4A09-9CDF-E7BA2B772A36Q34111824-93DD47CD-F3DC-4351-ACAE-781289156B07Q34188723-255321C7-CD01-4066-97AE-0424AAB6D332Q34503000-B0E2A71D-2525-47C8-8402-115C1133D318Q34590820-5EDC5BAC-CF0D-45FB-88C0-2B7EAFACDCB2Q34717034-88787097-2C60-4155-9B42-7D2ACB1924BFQ34993503-5DC2669B-ABCD-45AA-8E62-973DDD4E7463Q35585566-6713D1EB-BBEA-4E95-8C69-0374C620AD2FQ35671545-E8E89AFD-B035-4F66-9659-20E3437AD031Q35799663-7ACEA281-EBE0-43C8-8830-BF5A69901274Q36017728-E2511769-76C2-41D2-A1BD-D87C9410CF5BQ36108008-444394B2-1787-4E06-83E5-D59D0EFB670EQ36224502-DFB4E558-63A2-40E5-AB59-3960C7538EC6Q36353207-C3A29D3D-D05F-43DC-8419-175684AE8A1EQ36521830-07CE1472-2F4B-4A55-A4B0-0DDFFA9948D5Q36593767-9E3BDD86-E4DB-4C9F-A7D5-125E0BF5DBF9Q36610121-7A70A873-399C-419F-9741-EAC0F44A989DQ36639475-73CFB6DC-C81F-4091-8F15-E49150760E89Q36919283-F0A5F19E-D92C-4016-AA35-9AED9142F2D6Q36934947-356EDDE5-7E25-4600-B4D0-552DA79D9497Q37281368-3A4E672A-593C-4684-8F1B-6BFB836C3048Q37457750-733E0130-EF4D-4B13-BC9D-EB7E64BD3AFDQ37563712-8914BAF0-175D-465F-AE9A-39AE1D58FCC4Q37698501-C43C6C14-4481-4759-BE6A-0007BB9F2CA3Q37729253-38F463E6-B5B5-4059-88DE-7DB64112CA36Q37917774-387111BE-40BD-4B9E-92FB-BA2E6A54BF77Q37974301-B6AE9AF7-5A18-40F7-83C9-F6CC4D015E62Q38018319-74A74C0C-E6E9-4064-8388-3A2F7236A0FC
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tumor-infiltrating T lymphocytes: friends or foes?
@ast
Tumor-infiltrating T lymphocytes: friends or foes?
@en
type
label
Tumor-infiltrating T lymphocytes: friends or foes?
@ast
Tumor-infiltrating T lymphocytes: friends or foes?
@en
prefLabel
Tumor-infiltrating T lymphocytes: friends or foes?
@ast
Tumor-infiltrating T lymphocytes: friends or foes?
@en
P2860
P1476
Tumor-infiltrating T lymphocytes: friends or foes?
@en
P2093
P2860
P2888
P304
P356
10.1038/LABINVEST.3700389
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1040162771